Neoadjuvant TherapyPancreatic NeoplasmsCombined Modality TherapyChemoradiotherapy, AdjuvantPlatelet Glycoprotein GPIIb-IIIa ComplexChemotherapy, AdjuvantAdenocarcinomaPancreatectomyRadiotherapy, AdjuvantPancreaticoduodenectomyNeoplasm StagingPreoperative CareTreatment OutcomeFluorouracilCA-19-9 AntigenAntineoplastic Combined Chemotherapy ProtocolsSurvival RateRectal NeoplasmsEsophageal NeoplasmsLiver NeoplasmsEsophagectomyLung NeoplasmsCisplatinCarcinoma, Pancreatic DuctalPrognosisNeoplasm Recurrence, LocalHepatectomyPlatelet Membrane GlycoproteinsDeoxycytidineSurvival AnalysisDisease-Free SurvivalPlatelet Aggregation InhibitorsCarcinoma, Non-Small-Cell LungRetrospective StudiesCarcinoma, Squamous CellImmunoglobulin Fab FragmentsHypopharyngeal NeoplasmsMetastasectomyPeritoneal LavageColorectal NeoplasmsTomography, X-Ray ComputedRadiotherapy DosageKaplan-Meier EstimateInduction ChemotherapyPneumonectomyLeucovorinFollow-Up StudiesStomach NeoplasmsBlood PlateletsChemoradiotherapyGastrectomyProspective StudiesPlatelet AggregationOrganoplatinum CompoundsEsophagogastric JunctionAmpulla of VaterLaryngectomyLymphatic MetastasisAntimetabolites, AntineoplasticBile Duct NeoplasmsOropharyngeal NeoplasmsEndosonographyPositron-Emission TomographyRadiotherapyRandomized Controlled Trials as TopicMultivariate AnalysisHepatoblastomaAntibodies, MonoclonalTumor Markers, BiologicalTime FactorsPredictive Value of TestsMediastinumDigestive System Surgical ProceduresThrombastheniaCholangiocarcinomaCarcinoma, Large CellNeoplasm MetastasisFluorodeoxyglucose F18Carcinoma, Acinar CellLymph Node ExcisionFeasibility StudiesSarcomaDose FractionationAntigens, Human PlateletNeoplasm SeedingTaxoidsMultimodal ImagingAntineoplastic AgentsProportional Hazards ModelsDrug Administration SchedulePancreatitis, ChronicRetroperitoneal NeoplasmsLaryngeal NeoplasmsPostoperative ComplicationsInfusions, Intra-ArterialPlatelet ActivationChemoembolization, TherapeuticCarcinoma, HepatocellularRadiotherapy, Intensity-ModulatedCarcinoembryonic Antigen